Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 4/20 | 0.49 |
| ▸ | PSEN1 | P49768 | 14/20 | 0.42 |
| ▸ | PSEN2 | P49810 | 14/20 | 0.42 |
| ▸ | APH1B | Q8WW43 | 14/20 | 0.42 |
| ▸ | NCSTN | Q92542 | 14/20 | 0.42 |
| ▸ | APH1A | Q96BI3 | 14/20 | 0.42 |
| ▸ | PSENEN | Q9NZ42 | 14/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16059343 | 0.85 | CCR2 (0.36) | CCR2 | |
| SCHEMBL4618066 | 0.80 | CCR2 (0.38) | CCR2PSEN1PSEN2APH1BNCSTN | |
| Methyl Alcohol SCHEMBL28457179 | 0.78 | PSEN1 (0.45) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL3033354 | 0.77 | PSEN1 (0.47) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL3033357 | 0.77 | PSEN1 (0.47) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6263593 | 0.76 | CCR2 (0.41) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL29346027 | 0.76 | PSEN1 (0.44) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4188392 | 0.76 | L3MBTL1 (0.44) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4186722 | 0.74 | CCR2 (0.44) | CCR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL3108291 | 0.74 | MGLL (0.40) | CCR2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896036-A1 | ANTI-INFLAMMATORY AGENTS | Cambridge Enterprise Limited (GB) | 2008-03-12 | — | — | EP | claimed |
| WO-2006134384-A1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-12-21 | — | — | WO | claimed |
| EP-2401610-A1 | METHODS FOR IDENTIFICATION | Cambridge Enterprise Ltd. (GB) | 2012-01-04 | — | — | EP | disclosed |
| US-7803794-B2 | Anti-inflammatory agents | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-09-28 | — | — | US | disclosed |
| WO-2010097591-A1 | METHODS FOR IDENTIFICATION | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-09-02 | — | — | WO | disclosed |
| US-20100016286-A1 | Anti-Inflammatory Agents | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-01-21 | — | — | US | disclosed |
| EP-1896036-A1 | ANTI-INFLAMMATORY AGENTS | Cambridge Enterprise Limited (GB) | 2008-03-12 | — | — | EP | disclosed |
| EP-1896036-A1 | ANTI-INFLAMMATORY AGENTS | Cambridge Enterprise Limited (GB) | 2008-03-12 | — | — | EP | disclosed |
| WO-2006134384-A1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006134384-A1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016286-A1 | Anti-Inflammatory Agents | TNF, LTC4S, IL6 | CCR2 54/4885PSEN1 3780/4885PSEN2 4085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.